Want to find Targeted B2B leads? Slice and dice from over 84 million business prospects across 675+ industries, 400+ technologies, ad spend, and much more. Try it now for FREE!

How it works video / FAQ

Emisphere Technologies Inc.


Company Description: Emisphere is charting new frontiers in drug delivery. The Company's core business strategy is to use its proprietary Eligen® Technology to develop novel oral forms of injectable drugs or poorly absorbed compounds.

240 Cedar Knolls Rd Ste 200 Cedar Knolls, NJ 07927-1621

Industries: Startups

Technologies: Emisphere Technologies Inc. is using 3 Technologies.

Employees: We found 0 verified contacts and 76 unverified employees.

Social Media: Emisphere Technologies Inc. has 10 social media shares and likes.

We have 11 emails for Emisphere Technologies Inc..

Analytics Technology

Google Analytics
Google Analytics shows you the full customer picture across ads and videos, websites and social tools, tablets and smartphones. That makes it easier to serve your current customers and win new ones.

Social Media

Web Server Technology

Internet Information Services (IIS) for Windows Server is a flexible, secure and manageable Web server used for hosting anything on the internet.

Frameworks Technology

ASP.net is a free web framework for creating websites, apps, and services using HTML, CSS and JavaScript

Unverified Contacts

These are contacts we've discovered through publicly available sources and might be outdated.
Use our PerfectLink™ Contact Finder to verify contacts.

Michael Novinsky
Chairman & CEO
Paul Berk
Vice Chairman of Scientific Affairs
Bavani Shankar
Director Corporate Development
Jennifer Faircloth
Research Assistant, Quality Support Services
Gary Riley
VP Nonclinical Development/Applied Biology
Steven Sc. D
Vice President-Research and Technology Devel
Hina Patel
Associate Manager, Quality Assurance
Rich Connor
Assistant Vice President Quality and Analytica
Michael R Garone
VP/Interim CEO/CFO/Secy
Mike Garone
Chief Financial Officer
Scott Collins
Vice President Clinical Affairs
Alan L Rubino
Position of President and Chief Executive Officer
Karen Brazzillo
Director Program Management
Michael Weiser
David Gschneidner
Director, Senior Chemist
Muhammad Chowdhury
Research Associate
Bruce Variano
Facility Manager
John Weidner
Research Chemist
Peter Hutt
Sales Manager
Kimberly Keever
EHS Manager
Judy Lee
Business Development
John Maher
Technical Services Engineer
Jamila Harris
Research Associate
Halina Leuchyk
General Manager
Stephen Ip
Vice President Corporate Development
Koela Porter
Senior Manager
Ann Assuma
Ra Senior Director
Kenan Gu
Senior Scientist
Loretta A Miraglia
Patent Counsel
Destar... Moye-Sherman
Research Chemist
Joseph Povermo
Director Capital Budgeting
Sojan Paul
Research Associate
Mehmet Gurler
Associate Director
Gillian Racine
Investor Relations
Chantay Comans
Administrative Assistant
Jean Wang
Senior Research chemist
Robert Angelo
Vivien Wong
Senior Director
Stephanie Upshaw
Vice President
Ms Levin
BMC Communications Group
Nikia Jones
Sciencei Assistant
John Smart
Vice President
Jeffery Press
Engineering-R and D
Jere Goyan
Executive Director
Nadine Qashu
RA Manager
Maria Diblasi
Senior Accountant
Michael Goldberg
Account Manager
Joseph Robinson
Director and Scientific Advisor
Syed Ahmed
Research Associate
Brahma Singh
Michelle Martinez
Joseph Fotso
Kok Hew
Toxicology Professional
Mark Rachesky
Safety Director
Suraj Kalbag
Director of Pharma and Biochemistry
Kelly Stevens
Research Associate
Louise Jacobbi
Vice Chairperson of Public Affairs
William Bay
Margot Goodwin
Assistant Administrator II
Duncan Paton
Laboratory Director
Lisa Mileto
Daria Palestina
Director Human Resources
Sandra Budinsky
Vice Chairperson of Chapter Affairs
Michael Novinski
President and CEO
William Lyons
Vice Chairman of Development
Keith Lindor
Vice Chairman of Medical Affairs
Allan Dunton
President and COO
Bob Madison
Senior Director Corporate Communications
Isabel Gomez-Orellana
Director Strategic PLANNING
Noelle Whitehead
Chief Accounting Officer
Nadeje Halperin
Associate Director / Finance
Stephen Tresco
Specialist, Information Technology Operations
Lorraine Hilton
Manager Documentation Central
Alan Rubino
Timothy Rothwell
Carl Sailer
VP Sales

Additional Info and Employees

Emisphere offers Eligen Technology, which is used to develop novel oral forms of injectable drugs.


Michael R. Garone
Chief Financial Officer at EMISPHERE TECHNOLOGIES

Alan L. Rubino
President and Chief Executive Officer at EMISPHERE TECHNOLOGIES

emisphere.com Emails

Sign up to get full access to all the emisphere.com emails we have.





Find emails for Emisphere Technologies Inc. executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.